A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes

NCT06945406 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2

Interventions

DRUG: LY4057996 SC
DRUG: LY4057996 IV
DRUG: Placebo SC
DRUG: Placebo IV
DRUG: Degludec SC
DRUG: Lispro SC
DRUG: Degludec IV
DRUG: Pre-study basal insulin SC

Sponsor

Eli Lilly and Company